EN
HI
Summary
As of 14 Nov, 2026, Fredun Pharmaceuticals stock price is ₹1514. During the trading session, the stock has moved between an intraday low of ₹1511.30 and an intraday high of ₹1529.70. Over the last 52 weeks, Fredun Pharmaceuticals has traded between ₹1195.20 and ₹1665.00.
The stock has recorded a trading volume of 2,190 shares,. Its Average Traded Price (ATP) is ₹1517.47, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹1514.00.
Fredun Pharmaceuticals has an upper circuit limit of ₹1832.70 and a lower circuit limit of ₹1221.90. The total value traded stands at ₹33.23 L, and the delivery percentage for the day is 48.47%.
The stock is currently traded with a market lot size of 1. Fredun Pharmaceuticals also offers a dividend yield of 0.02%.
Fredun Pharmaceuticals Share Price Chart
Fredun Pharmaceuticals Share Key Metrics
Volume
2190.00
Market Cap
2482.03 CR
LTQ@LTP
2@1514.00
ATP
1517.47
Var Margin
25.44 %
Circuit Range
1221.9-1832.7
Delivery %
48.47 %
Value
33.23 L
ASM/GSM
No
Market Lot
1
Fredun Pharmaceuticals Fundamentals
P/E Ratio
48.54
P/B Ratio
7.42
Div. Yield
0.02
Sector P/E
41.18
Sector P/B
2.49
Sec. Div. Yield
0.53
Fredun Pharmaceuticals Resistance and Support
Pivot 1518.77
Resistance
First Resistance
1553.54
Second Resistance
1579.77
Third Resistance
1614.54
Support
First Support
1492.54
Second Support
1457.77
Third Support
1431.54
Fredun Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 1530 | 1500.8 | -1.74% | 1530 | 1497 |
| Thu Nov 12 2026 | 1484 | 1527.3 | 2.19% | 1545 | 1484 |
| Wed Nov 11 2026 | 1535 | 1494.59 | -1.63% | 1546 | 1486 |
Fredun Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
| 2025-09-25 | Preferential Issue of shares & Others |
| 2026-08-05 | Quarterly Results |
| 2026-05-25 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-07-30 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-04 | Quarterly Results |
| 2024-10-26 | Quarterly Results |
| 2024-10-03 | Others |
| 2024-07-29 | Quarterly Results |
Fredun Pharmaceuticals News
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fredun Pharmaceuticals reported a 94% YoY jump in H1 FY27 net profit to Rs.31.99 crores, with total income surging 87% YoY to Rs.495.88 crores. The company also announced the acquisition of pet-wellness brand Furlicks and a 26% stake in Goodman Vetcare.
Nov 06 2026 09:02:19
Fredun Pharmaceuticals Ltd - 539730 - Revised Outcome Of The Board Meeting
Fredun Pharmaceuticals' board has approved a proposal to apply for the listing of its equity shares on the National Stock Exchange (NSE). The application is subject to applicable laws and necessary regulatory approvals.
Nov 05 2026 19:11:01
Read More
Fredun Pharmaceuticals Management
| Name | Position |
|---|---|
| Daisy Dsouza | Non Executive Independent Director |
| Sonal Desai | Non Executive Independent Director |
Fredun Pharmaceuticals Similar Stocks
Solara Active Pharma Sciences Ltd.
693.60
17.35 (2.57%)
Ind-Swift Laboratories Ltd.
359.55
-0.80 (0.22%)
Advanced Enzyme Technologies Ltd.
269.00
-15.10 (5.32%)
Hikal Ltd.
223.81
0.21 (0.09%)
Dishman Carbogen Amcis Ltd.
173.02
-1.08 (0.62%)
Dr Agarwals Eye Hospital Ltd.
6029.50
4.00 (0.07%)
Sakar Healthcare Ltd.
1068.60
-3.70 (0.35%)
Sai Parenteral's Ltd.
505.90
3.75 (0.75%)
Panacea Biotec Ltd.
358.40
-3.10 (0.86%)
Fredun Pharmaceuticals FAQs
The Buying Price of Fredun Pharmaceuticals share is 1514 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Fredun Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Fredun Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Fredun Pharmaceuticals shares is 48.54. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Fredun Pharmaceuticals shares is 7.42. Useful to assess the stock's value relative to its book value.
To assess Fredun Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.18 & 2.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Fredun Pharmaceuticals is 2482.03 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Fredun Pharmaceuticals share price is 1665.00 & 1195.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Fredun Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in FREDUN
